Stem Cell Therapy Market Outlook, Opportunities, Demand and Forecasts 2022- 2030
Stem Cell Therapy Market
Overview
Stem
cell therapy involves harvesting and processing a patient's own stem cells,
which are then populated on bio-absorbable polymer scaffold and surgical
implants. It dramatically exceeds outcomes achieved with existing conventional
treatment. Therefore, stem cell therapy now represents the biotechnology
industry's dominant, incumbent technology. Over the recent year, the stem cell
therapy is gaining a huge market prominence, mainly due to its efficacy proven
in the treatments of many chronic diseases such as diabetes, hematopoietic
disorders, and degenerative disorders, among others.
Resultantly,
the global Stem Cell Therapy Market is rising pervasively, witnessing increasing uptake of this
therapeutics. The market is exploding with a number of researches currently
ongoing, and there have been several breakthrough outcomes as well. According to
Market Research Future (MRFR), the global stem cell therapy market is booming
and expected garner fabulous accruals by 2030. In its recent market analysis,
MRFR also asserts that the market would register around 10.74% CAGR throughout
the review period (2022–2030).
The
market is predominantly driven by the growing prevalence of various chronic
diseases such as cancer, diabetes, hematopoietic disorders (leukemia,
thalassemia, and others), degenerative disorders (osteoarthritis, Alzheimer's
disease, Parkinson's disease, chronic renal failure, congestive cardiac
failure,) and others. Additionally, enormously rising demand for stem cell
therapy to control the growth of the above-mentioned diseases and disorders
boost the market growth. Substantial investments made in R&D initiatives by
government and private companies influence the growth of the market.
Stem
Cell Therapy Market - Segments
MRFR
has segmented the report into five dynamics to widen the scope of
understanding,
By
Technique : Primary (Direct) Stem Cell Therapy,
Secondary (Indirect) Stem Cell Therapy, Salt Split Technique, Antigenic Mapping
Method, Double Staining Method, Micro Immunofluorescence, and others.
By
Product
Type :
Antibodies, Kits & Reagents, Instruments, Microscopes, Imaging Analysis
Systems, Labeling Dyes & Species Product Type, and others.
By
Application : Clinical research, Clinical Diagnostics,
Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases,
Neurological Diseases, Research & Development, and others.
By
End-user :
Biotechnology Companies, Hospitals & Research Institutes, Contract Research
Organizations, Diagnostic Centers, and others.
By
Region :
Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World
Stem
Cell Therapy Market Regional Analysis
Based on region,
the stem
cell therapy market segmented into the Americas, Europe, Asia-Pacific and the
Middle East and Africa. The Americas lead the market on account of factors such
as growing healthcare expenditure and existence of heart diseases. After the
Americas, Europe (Netherlands, France, Belgium and UK) grabs the second position. This can be attributed to factors
such as the rising occurrence of osteoarthritis, cancer and stroke.
It is the Asia-Pacific
which is the fastest growing region in this market and is likely to see further
growth due to the increasing existence of smoking here. The Middle East &
Africa (MEA) region holds a relatively smaller share of market due to lack of
well-trained healthcare experts and low per capita income. However, both the
increasing technology and oncology in the community and the hospital level are
likely to positively influence the stem cell therapy market.
Key
Players
Stem Cell Therapy Market Players include
Thermo Fisher Scientific Inc, AlloSource (US), RTI Surgical Inc (US), NuVasive
Inc (US), JCR Pharmaceuticals Co. Ltd (Japan), HolostemTerapieAvanzateS.r.l.
(Italy), Pharmicell Co., Ltd (South Korea), Anterogen Co., Ltd (South Korea),
MEDIPOST Co., Ltd (South Korea), and Orisis Therapeutics, Inc. (US).
Latest research in
September, 2018 jointly led by University of Pennsylvania and Fourth Military
Medicine University revealed that stem cells from baby teeth can be harvested
which will have prospective dental uses to repair and regenerate tissues and
regrow the adult teeth without the need for dentures or crowns.
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment